Overweight and obesity Management
Abstract
No available
References
Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63:2985-3023.
Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129:S102-38.
Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-5.
Garvey WT, Garber AJ, Mechanick JI, et al. American association of clinical endocrinologists and american college of endocrinology position statement
on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocrine Practice : official journal of the American College of Endocrinology
and the American Association of Clinical Endocrinologists. 2014;20:977-89.
Garvey WT, Garber AJ, Mechanick JI, et al. American association of clinical endocrinologists and american college of endocrinology consensus conference
on obesity: building an evidence base for comprehensive action. Endocrine Practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2014;20:956-76.
Obesity: Identification, Assessment and Management of Overweight and Obesity in Children, Young People and Adults: Partial Update of CG43. London; 2014.
Wadden TA, Berkowitz RI, Womble LG, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 2005;353:2111-20.
Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an endocrine Society clinical practice guideline. J Clin Endocrinol
Metab. 2015;100:342-62.
Da Silva JA, Jacobs JW, Bijlsma JW. Revisiting the toxicity of low-dose glucocorticoids: risks and fears. Ann NY Acad Sci. 2006;1069:275-88.
Ratliff JC, Barber JA, Palmese LB, Reutenauer EL, Tek C. Association of prescription H1 antihistamine use with obesity: results from the National Health and Nutrition Examination Survey. Obesity. 2010; 18:2398-400.
Weintraub M, Sundaresan PR, Schuster B, et al. Longterm weight control study. II (weeks 34 to 104). An open-label study of continuous fenfluramine plus
phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise. Clin Pharmacol Ther. 1992;51:595-601.
Hendricks EJ, Srisurapanont M, Schmidt SL, et al. Addiction potential of phentermine prescribed dur-ing long-term treatment of obesity. Intern J Obesity.
;38:292-8.
OûNeil PM, Smith SR, Weissman NJ, et al. Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOMDM
study. Obesity. 2012;20:1426-36.
Ruof J, Golay A, Berne C, Collin C, Lentz J, Maetzel A. Orlistat in responding obese type 2 diabetic patients: meta-analysis findings and cost-effectiveness as rationales for reimbursement in Sweden and Switzerland. Int J Obes. 2005;29:517-23.
Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27:155-61.
Garvey WT, Ryan DH, Look M, et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and
overweight adults (SEQUEL): a randomized, placebocontrolled, phase 3 extension study. Am J Clin Nutr.2012;95:297-308.
Gadde KM, Allison DB, Ryan DH, et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377:1341-52.
Garvey WT, Ryan DH, Bohannon NJ, et al. Weightloss therapy in type 2 diabetes: effects of phentermine and topiramate extended release. Diabetes Care.
;37:3309-16.
Astrup A, Carraro R, Finer N, et al. Safety, tolerability and sustained weight loss over 2 years with the oncedaily oncedaily human GLP-1 analog, liraglutide. Intern J Obes 2012;36:843-54.
Fried M, Hainer V, Basdevant A, et al. Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obes. 2007;31:569-77.
Bult MJ, van Dalen T, Muller AF. Surgical treatment of obesity. Eur J Endocrinol / European Federation of Endocrine Societies. 2008;158:135-45.
DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med. 2007;356:2176-83.
Restrictive surgery for weight loss. Accees from: http://www.webmd.com/diet/weight-loss-surgery/restrictive-surgery วันที่ 26 มิถุนายน 2556.
Biliopancreatic diversion at NJ bariatrics. Accees from:http://www.njbariatricspc.com/bariatric-surgerytypes/biliopancreatic-diversion-nj/2556.
Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273:219-34.
Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA: the journal of the American Medical Association
;307:56-65.
Maggard MA, Shugarman LR, Suttorp M, et al. Metaanalysis: surgical treatment of obesity. Ann Intern Med 2005;142:547-59.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA : the journal of the American Medical Association
;292:1724-37.
Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-52.
Downloads
Published
How to Cite
Issue
Section
License
The content and information in the articles published in Thai JPEN วารสารโภชนบำบัด, are the opinions and responsibility of the authors directly. The editorial team is not obliged to agree or take any responsibility.
All articles, content, figures, etc. that have been published in Thai JPEN วารสารโภชนบำบัด are the copyright of Thai JPEN วารสารโภชนบำบัด. If any person or organization require distribution of all or any part of them, please send the request for the written permission from Thai JPEN วารสารโภชนบำบัด only.
